Veterinary Eye Care Market
Veterinary Eye Care Market Study by Medical Treatment and Surgery for Ocular Surface Disorders, Glaucoma, Cataract, Anterior Uveitis, Retinal Diseases, Corneal Diseases, and Others From 2024 to 2034
Analysis of Veterinary Eye Care Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Veterinary Eye Care Market Outlook (2024 to 2034)
Worldwide revenue from the demand for veterinary eye care market is estimated to stand at a value of US$ 80.23 million in 2024 and is slated to increase at a CAGR of 5.2% to reach US$ 133.15 million by 2034.
Growth in pet insurance coverage for ocular procedures, developments in technology for veterinary ophthalmic illnesses, and an increase in the ophthalmic manifestation of veterinary ailments are the main drivers driving the market. The necessity for expert care of common eye problems in animals is increasing due to their ever-increasing population.
Common ocular issues in these species include cataracts, uveitis, conjunctivitis, corneal and retinal difficulties, anomalies of the eyelids, and others. Veterinarian eye care is an essential part of veterinary medicine, focusing on the diagnosis, treatment, and prevention of injuries and ocular diseases in a range of animal species.
Similar to people, animals also get a range of eye disorders that require veterinary specialists to treat them. This market is expanding further because of the increasing frequency of conditions ranging from simple illnesses, including conjunctivitis to more complex conditions, such as cataracts or glaucoma. Cats with systemic disorders also frequently experience ocular and associated anatomical problems. Eyelid inflammation has been related to immune-mediated skin diseases, ringworm, and scabies. Infectious illnesses in cats are caused by common infections. Feline herpesvirus 1 (FHV-1), Chlamydia, and Mycoplasma are some other examples.
Acute vision loss in elderly cats, accompanied by retinal detachment and intraocular hemorrhage, is often associated with hyperthyroidism or chronic renal failure and is attributable to systemic hypertension. Conversely, equine influenza, strangles (Streptococcus equi), infection from Rhodococcus equi, leptospirosis, conjunctivitis, anterior or posterior uveitis, and salmonellosis all manifest in horses.
Furthermore, in cattle, hydrocephalus and in-utero infection of calves with bovine viral diarrhea are related to microphthalmia, cataracts, retinal dysplasia, and retinal detachments. The same eye problems affect lambs infected with the bluetongue virus when they are still in utero. In swine, vitamin A deficiency results in microphthalmia; in calves, it causes blindness and optic nerve hypoplasia.
| Report Attributes | Details |
|---|---|
| Veterinary Eye Care Market Size (2024E) | US$ 80.23 Million |
| Forecasted Market Value (2034F) | US$ 133.15 Million |
| Global Market Growth Rate (2024 to 2034) | 5.2% CAGR |
| Middle East & Africa Market Value (2024E) | US$ 2.85 Million |
| Mexico Market Value (2034F) | US$ 2.68 Million |
| Surgery Segment Growth Rate (2024 to 2034) | 5.1% CAGR |
| India Market Value (2034F) | US$ 8.02 Million |
| Key Companies Profiled | Novartis AG; CooperVision; Essilor; Grandvision; Alcon; Menicon; Carl Zeiss AG |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why There is excelling demand for ophthalmologic treatment in Vet Eye Care?
The large adoption of pets and increasing awareness about eye disorders have encouraged veterinary eye care providers to improve the quality of their products and develop effective therapies that ensure the speedy recovery of pets. In addition, technological advancements in the healthcare industry have been helping medical practitioners to provide painless surgeries, which is gaining momentum in the veterinary eye care market.
The global veterinary eye care market is expected to witness moderate growth over the forecast period. Several veterinary drugs are introduced in the market. Of these, some are still under clinical trials and thus, there is high competition among local and regional players. Among the two treatment types, the medical treatment segment, which includes eye drops, ointments, and drugs, is expected to lead the global veterinary eye care industry over the forecast period.
What Restraints in this market are Companies Projected to face?
- Hesitance in the adoption of advanced eye care infrastructure, on the back of high initial investment costs, is expected to limit the growth of the veterinary eye care market.
- Lack of awareness about the eye care of pets in developing countries and average healthcare facilities to dampen the growth of the veterinary eye care market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Regional Outlook
Vet eye care is expected to gain the maximum share in North America owing to rising healthcare infrastructure. There is a greater concentration of key players in this market who are consistently bringing innovation and are expected to gain traction in the forecast period.
Europe will hold the second position in the veterinary eye care market, which is attributed to the popular trends of pet adoption and excellent pet insurance policies. However, Asia Pacific to witnessing sluggish growth of the veterinary eye care market with slow traction of pet adoption propensities.
Segment wise Insights
The retail pharmacy distribution channels segment is expected to contribute a high share of the global pet eye care market as it is the most accessible channel and outpatient treatment is recommended for most animals. Veterinary hospitals also account for significant revenue generation in the vet eye care market owing to a large number of eye surgeries performed by veterinarians in these facilities.
Based on end users, this market is dominated by vet hospitals and veterinary clinics. Alongside these hospitals are anticipated to experience a rise in patients due to increasing eye issues in pets in the forecast duration.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive landscape
The veterinary eye care market has been growing on account of the key developments proposed and implemented by the key players. The global veterinary eye care market is highly fragmented owing to the presence of a large number of domestic manufacturers. These players have been strengthening their position in the market by leveraging expansion strategies. In addition, an increase in funding has offered a smooth path for the advancements of these veterinary eye care market players.
Some of the key players operating in the veterinary eye care market constitute Akorn, Inc., Animal Eye Care LLC, Menicon Co., Ltd., I-Med Animal Health, and Bausch & Lomb Incorporated. Some of the novel developments implemented by these companies are discussed below.
- Mergers and acquisitions have been a strategy for availing two-way benefits for the companies. Along the same lines, Pathway acquired Eye Care for Animals (ECFA) in 2017, to leverage ECFA’s growth model and stay sustainable in the intensely competitive veterinary eye care market.
- In April 2018, Mars Petcare completed the acquisition of OptiGen LLC, to conduct the highest quality of DNA testing, especially for dogs. This testing will help in detecting several health risks among mixed-breed dogs.
- Recently, I-Med Pharma entered into an agreement with DryCom to open up a distribution channel for the I-PEN Tear Osmolarity System in Brazil.
Segmentation of the Veterinary Eye Care Market Research
-
By Treatment :
- Medical Treatment
- Surgery
-
By Indications :
- Ocular Surface
- Glaucoma
- Cataract
- Anterior Uveitis
- Retinal Diseases
- Corneal Diseases
- Others
-
By Distribution Channel :
- Veterinary Hospitals
- Veterinary Clinics
- Veterinary Pharmacies
- Drug Stores
- Online Pharmacies
- Others
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Treatment 6.2. Indications 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Treatment 7.1. Medical Treatment 7.2. Surgery 8. Global Market Analysis and Forecast, By Indications 8.1. Ocular Surface Disorders 8.2. Glaucoma 8.3. Cataract 8.4. Anterior Uveitis 8.5. Retinal Diseases 8.6. Corneal Disease 8.7. Others 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Veterinary Hospitals 9.2. Veterinary Clinics 9.3. Retail Pharmacies 9.4. Drug Stores 9.5. Online Pharmacy 9.6. Others 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. MEA 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. MEA Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Treatment, Indications, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Akorn, Inc. 20.2. Animal Eye Care LLC 20.3. Menicon Co., Ltd. 20.4. I-Med Animal Health
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Treatment
Table 3: Global Market US$ Mn Forecast by Indications
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Treatment
Table 7: North America Market US$ Mn Forecast by Indications
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Treatment
Table 11: Latin America Market US$ Mn Forecast by Indications
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Treatment
Table 15: Western Europe Market US$ Mn Forecast by Indications
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Treatment
Table 19: Eastern Europe Market US$ Mn Forecast by Indications
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Treatment
Table 23: East Asia Market US$ Mn Forecast by Indications
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Treatment
Table 27: South Asia & Pacific Market US$ Mn Forecast by Indications
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Treatment
Table 31: MEA Market US$ Mn Forecast by Indications
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
Table 33: Latin America Market US$ Mn Forecast by Country
Table 34: Latin America Market US$ Mn Forecast by Treatment
Table 35: Latin America Market US$ Mn Forecast by Indications
Table 36: Latin America Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 33: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 34: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 35: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 36: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the Veterinary eye care industry in 2024?
The global market for veterinary eye care is at present valued at US$ 80.23 million.
What is the forecasted growth rate of the vet eye care market?
The market is approximated to expand at a CAGR of 5.2% from 2024 to 2034.
What is the future outlook for this market?
The industry is projected to reach a worth of US$ 133.15 million by the end of 2034.
What are the factors driving demand for vet eye care?
Increasing adoption of companion animals coupled with rising pet insurance is driving the demand for veterinary eye care.
Veterinary Eye Care Market